State Street’s iTeos Therapeutics ITOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.93M Buy
594,555
+12,558
+2% +$125K ﹤0.01% 2857
2025
Q1
$3.47M Sell
581,997
-3,939
-0.7% -$23.5K ﹤0.01% 3030
2024
Q4
$4.5M Sell
585,936
-589,417
-50% -$4.53M ﹤0.01% 3021
2024
Q3
$12M Buy
1,175,353
+211,452
+22% +$2.16M ﹤0.01% 2500
2024
Q2
$14.3M Buy
963,901
+386,356
+67% +$5.73M ﹤0.01% 2342
2024
Q1
$7.88M Buy
577,545
+25,990
+5% +$355K ﹤0.01% 2716
2023
Q4
$6.04M Sell
551,555
-1,029,938
-65% -$11.3M ﹤0.01% 2859
2023
Q3
$17.3M Buy
1,581,493
+16,291
+1% +$178K ﹤0.01% 2249
2023
Q2
$20.7M Sell
1,565,202
-262,189
-14% -$3.47M ﹤0.01% 2229
2023
Q1
$24.9M Buy
1,827,391
+90,101
+5% +$1.23M ﹤0.01% 2081
2022
Q4
$33.9M Sell
1,737,290
-370,578
-18% -$7.24M ﹤0.01% 1894
2022
Q3
$40.2M Sell
2,107,868
-370,464
-15% -$7.06M ﹤0.01% 1757
2022
Q2
$51.1M Buy
2,478,332
+766,441
+45% +$15.8M ﹤0.01% 1620
2022
Q1
$55.1M Buy
1,711,891
+948,540
+124% +$30.5M ﹤0.01% 1692
2021
Q4
$35.5M Buy
763,351
+441,244
+137% +$20.5M ﹤0.01% 2057
2021
Q3
$8.7M Buy
322,107
+3,938
+1% +$106K ﹤0.01% 2963
2021
Q2
$8.16M Sell
318,169
-384,841
-55% -$9.87M ﹤0.01% 3016
2021
Q1
$24M Buy
703,010
+514,008
+272% +$17.6M ﹤0.01% 2250
2020
Q4
$6.39M Buy
189,002
+57,773
+44% +$1.95M ﹤0.01% 2845
2020
Q3
$3.24M Buy
+131,229
New +$3.24M ﹤0.01% 3002